Literature DB >> 1793458

Proteolytic inactivation of alpha-1-anti-chymotrypsin. Sites of cleavage and generation of chemotactic activity.

J Potempa1, D Fedak, A Dubin, A Mast, J Travis.   

Abstract

The effect of several microbial and mammalian proteinases on the inhibitory activity of human plasma alpha-1-anti-chymotrypsin (alpha-1-Achy) has been tested. Most of these enzymes caused rapid inactivation of the inhibitor by cleavage at single sites within the reactive-site loop between P5 Lys and P3' Leu, with additional cleavages also being detected in some cases near the NH2 terminus of the native protein. In contrast, two of the enzymes tested failed to inactivate alpha-1-Achy, although they could cause removal of peptides near the NH2 terminus. Studies of neutrophil chemotaxis revealed that native or NH2-terminally truncated alpha-1-Achy was not stimulatory. However, testing of two enzymatically inactivated forms of the inhibitor (alpha-1-Achy), cleaved at widely different positions within the reactive-site loop, indicated that they had become potent chemoattractants at concentrations within the nanomolar range. Competition studies using proteolytically inactivated alpha-1-proteinase inhibitor suggested that the chemotactic activity of the two inactivated serpins was probably mediated by the same mechanism. The physiological relevance of this chemotactic activity is underscored by the results of plasma elimination studies which indicate that alpha-1-Achy is eliminated at approximately the same rate as native alpha-1-Achy, thus prolonging chemotactic stimuli within the tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793458

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Two allelic forms of the aureolysin gene (aur) within Staphylococcus aureus.

Authors:  A Sabat; K Kosowska; K Poulsen; A Kasprowicz; A Sekowska; B van Den Burg; J Travis; J Potempa
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Staphylococcal proteases aid in evasion of the human complement system.

Authors:  Monika Jusko; Jan Potempa; Tomasz Kantyka; Ewa Bielecka; Halie K Miller; Magdalena Kalinska; Grzegorz Dubin; Peter Garred; Lindsey N Shaw; Anna M Blom
Journal:  J Innate Immun       Date:  2013-07-03       Impact factor: 7.349

3.  Miropin, a novel bacterial serpin from the periodontopathogen Tannerella forsythia, inhibits a broad range of proteases by using different peptide bonds within the reactive center loop.

Authors:  Miroslaw Ksiazek; Danuta Mizgalska; Jan J Enghild; Carsten Scavenius; Ida B Thogersen; Jan Potempa
Journal:  J Biol Chem       Date:  2014-11-11       Impact factor: 5.157

4.  Pivotal role for alpha1-antichymotrypsin in skin repair.

Authors:  Daniel C Hoffmann; Christine Textoris; Felix Oehme; Tobias Klaassen; Andreas Goppelt; Axel Römer; Burkhard Fugmann; Jeffrey M Davidson; Sabine Werner; Thomas Krieg; Sabine A Eming
Journal:  J Biol Chem       Date:  2011-06-21       Impact factor: 5.157

5.  Association of alpha(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis.

Authors:  R Mahadeva; L Sharples; R I Ross-Russell; A K Webb; D Bilton; D A Lomas
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

6.  Studies on inhibition of neutrophil cathepsin G by alpha 1-antichymotrypsin.

Authors:  P A Patston
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

7.  The serpin-enzyme complex (SEC) receptor mediates the neutrophil chemotactic effect of alpha-1 antitrypsin-elastase complexes and amyloid-beta peptide.

Authors:  G Joslin; G L Griffin; A M August; S Adams; R J Fallon; R M Senior; D H Perlmutter
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1-antichymotrypsin.

Authors:  Yuan-Ping Han; Chunli Yan; Warren L Garner
Journal:  J Invest Dermatol       Date:  2008-04-10       Impact factor: 8.551

9.  Variation in extracellular protease production among clinical isolates of Staphylococcus aureus due to different levels of expression of the protease repressor sarA.

Authors:  Anna Karlsson; Staffan Arvidson
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  Polymorphism, genetic exchange and intragenic recombination of the aureolysin gene among Staphylococcus aureus strains.

Authors:  Artur J Sabat; Benedykt Wladyka; Klaudia Kosowska-Shick; Hajo Grundmann; Jan Maarten van Dijl; Julia Kowal; Peter C Appelbaum; Adam Dubin; Waleria Hryniewicz
Journal:  BMC Microbiol       Date:  2008-07-29       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.